SCHEMBL6572365

SCHEMBL6572365

CC(=O)OCC(=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311876 0.85 ALDH1A1 (0.53)
SCHEMBL2706963 0.80 ALDH1A1 (0.48)
SCHEMBL342382 0.79 GLO1 (0.32)
SCHEMBL197897 0.78
SCHEMBL12814201 0.78
SCHEMBL713608 0.78
SCHEMBL21715100 0.76
SCHEMBL5171320 0.76 ALDH1A1 (0.43)
SCHEMBL4645361 0.76 ALDH1A1 (0.43)
SCHEMBL30662414 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896711-B2 Fluorogenic or fluorophoric compounds and uses thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-02-20 US disclosed
US-20160340709-A1 FLUOROGENIC OR FLUOROPHORIC COMPOUNDS AND USES THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2016-11-24 US disclosed
US-9434975-B2 Fluorogenic or fluorophoric compounds and uses thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2016-09-06 US disclosed
US-9193740-B2 Bismacrocyclic compounds as hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-11-24 US disclosed
EP-2691383-B1 FLUOROGENIC OR FLUOROPHORIC COMPOUNDS AND USES THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2015-01-21 EP disclosed
US-20140186878-A1 FLUOROGENIC OR FLUOROPHORIC COMPOUNDS AND USES THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-07-03 US disclosed
EP-2691383-A1 FLUOROGENIC OR FLUOROPHORIC COMPOUNDS AND USES THEREOF 3M Innovative Properties Company (US) 2014-02-05 EP disclosed
WO-2012134724-A1 FLUOROGENIC OR FLUOROPHORIC COMPOUNDS AND USES THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-10-04 WO disclosed
WO-2007065524-A1 ERYTHRULOSE ESTERS AS UV FILTERS MERCK PATENT GMBH (DE) 2007-06-14 WO disclosed
EP-1009377-A4 MEDICAL USES OF PYRUVATES UNIV CASE WESTERN RESERVE (US) 2004-01-21 EP disclosed
US-6086789-A SKIN INJURIES CASE WESTERN RESERVE UNIVERSITY (US) 2000-07-11 US disclosed
EP-1009377-A1 MEDICAL USES OF PYRUVATES Case Western Reserve University (US) 2000-06-21 EP disclosed
US-5968727-A SOLUTION FOR LONG TERM PRESERVATION OF TRANSPLANTABLE ORGANS DEPRIVED OF OXYGEN CASE WESTERN RESERVE UNIVERSITY (US) 1999-10-19 US disclosed
US-5876916-A ADMINISTRATION OF GLYCEROL-PYRUVATE OR HYDROXYACETONE PYRUVATE ESTER WITH BIOCOMPATIBLE CARRIER TO MAMMALS; AS HIGH CALORIE FOOD, ANTICHOLESTEROL AGENTS, ANTIISHEMIC AGENTS, ORGAN PRESERVATIVE, ANTIDIABETIC AGENTS CASE WESTERN RESERVE UNIVERSITY (US) 1999-03-02 US disclosed
EP-0888267-A1 NOVEL PYRUVATE COMPOUNDS AND METHODS FOR USE THEREOF CASE WESTERN RESERVE UNIVERSITY (US) 1999-01-07 EP disclosed
WO-1998051277-A1 MEDICAL USES OF PYRUVATES CASE WESTERN RESERVE UNIVERSITY (US) 1998-11-19 WO disclosed
WO-1997034856-A1 NOVEL PYRUVATE COMPOUNDS AND METHODS FOR USE THEREOF CASE WESTERN RESERVE UNIVERSITY (US) 1997-09-25 WO disclosed
US-4957912-A ANTIBIOTICS MERCK & CO., INC. (US) 1990-09-18 US disclosed
US-4226866-A BACTERICIDES, ACYLATION MERCK & CO., INC. (US) 1980-10-07 US disclosed